(Q45403775)

14 December 2017

Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple (English)

1 reference

14 December 2017

1 reference

Fernando P Polack

1

1 reference

PubMed ID

17515829

14 December 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

14 December 2017

1 reference

14 December 2017

62

1 reference

14 December 2017

1

1 reference

14 December 2017

111-115

1 reference

https://scigraph.springernature.com/pub.10.1203/pdr.0b013e3180686ce0

14 December 2017

0 references

cites work

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Atypical Measles in Adolescents and Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Skin tests with measles and poliomyelitis vaccines in recipients of inactivated measles virus vaccine. Delayed dermal hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Altered reactivity to measles virus: local reactions following attenuated measles virus immunization in children who previously received a combination of inactivated and attenuated vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Reactions to Live-Measles-Virus Vaccine in Children Previously Inoculated with Killed-Virus Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Differences in the Appearance of Antibodies to Structural Components of Measles Virus after Immunization with Inactivated and Live Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

A role for immune complexes in enhanced respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180686CE0

10.1203/PDR.0B013E3180686CE0

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

17515829

Dimensions Publication ID

14 December 2017

0 references

1 reference

PubMed ID

17515829